Patents by Inventor Angela Rosaria SOLANO

Angela Rosaria SOLANO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210259995
    Abstract: Compositions and methods for inhibiting tumor growth, particularly breast cancer, in a combined pharmacological treatment. A pharmaceutical combination for inhibiting growth of a tumor overexpressing ACSL4, comprising a first and a second dosage forms. The first dosage form has an ACSL4 inhibitor and the second dosage form has a chemotherapeutic agent.
    Type: Application
    Filed: May 6, 2021
    Publication date: August 26, 2021
    Inventors: Ernesto Jorge PODESTÁ, Ana Fernanda CASTILLO, Ulises Daniel ORLANDO, Paula Mariana MALOBERTI, Angela Rosaria SOLANO
  • Publication number: 20190269629
    Abstract: Compositions and methods for inhibiting tumor growth, particularly breast cancer, in a combined pharmacological treatment. A pharmaceutical combination for inhibiting growth of a tumor overexpressing ACSL4, having a first and a second dosage forms. The first dosage form has an ACSL4 inhibitor and the second dosage form has a chemotherapeutic agent.
    Type: Application
    Filed: November 3, 2017
    Publication date: September 5, 2019
    Inventors: Ernesto Jorge PODESTÁ, Ana Fernanda CASTILLO, Ulises Daniel ORLANDO, Paula Mariana MALOBERTI, Angela Rosaria SOLANO
  • Patent number: 9737515
    Abstract: The present invention relates to compositions and methods for preventing and treating cell proliferation in cancer. More specifically, the present invention relates to compositions and methods for inhibiting tumor growth, and for treating proliferative diseases, particularly colon and breast cancer, with a combined pharmacological approach. Yet more specifically, the compositions for inhibiting tumor growth comprise a combination of: i) a first component which is an ACSL4 inhibitor; and ii) a second component selected from the group consisting of mTOR inhibitor and ER inhibitor.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: August 22, 2017
    Assignee: Consejo Nacional De Investigaciones Cientificas Y Tecnicas (CONICET)
    Inventors: Ernesto Jorge Podesta, Paula Mariana Maloberti, Ulises Daniel Orlando, Melina Andrea Dattilo, Ana Fernanda Castillo, Angela Rosaria Solano
  • Publication number: 20160303090
    Abstract: The present invention relates to compositions and methods for preventing and treating cell proliferation in cancer. More specifically, the present invention relates to compositions and methods for inhibiting tumor growth, and for treating proliferative diseases, particularly colon and breast cancer, with a combined pharmacological approach. Yet more specifically, the compositions for inhibiting tumor growth comprise a combination of: i) a first component which is an ACSL4 inhibitor; and ii) a second component selected from the group consisting of mTOR inhibitor and ER inhibitor.
    Type: Application
    Filed: March 2, 2016
    Publication date: October 20, 2016
    Inventors: Ernesto Jorge PODESTA, Paula Mariana MALOBERTI, Ulises Daniel ORLANDO, Melina Andrea DATTILO, Ana Fernanda CASTILLO, Angela Rosaria SOLANO